Phathom Pharmaceuticals (PHAT) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$1.5 billion.
- Phathom Pharmaceuticals' Retained Earnings fell 2309.94% to -$1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year decrease of 2309.94%. This contributed to the annual value of -$1.3 billion for FY2024, which is 3599.99% down from last year.
- Phathom Pharmaceuticals' Retained Earnings amounted to -$1.5 billion in Q3 2025, which was down 2309.94% from -$1.4 billion recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Retained Earnings registered a high of -$570.0 million during Q1 2022, and its lowest value of -$1.5 billion during Q3 2025.
- Moreover, its 4-year median value for Retained Earnings was -$928.7 million (2023), whereas its average is -$983.9 million.
- As far as peak fluctuations go, Phathom Pharmaceuticals' Retained Earnings tumbled by 3997.63% in 2024, and later plummeted by 2309.94% in 2025.
- Quarter analysis of 4 years shows Phathom Pharmaceuticals' Retained Earnings stood at -$727.1 million in 2022, then decreased by 27.73% to -$928.7 million in 2023, then crashed by 36.0% to -$1.3 billion in 2024, then fell by 15.84% to -$1.5 billion in 2025.
- Its Retained Earnings stands at -$1.5 billion for Q3 2025, versus -$1.4 billion for Q2 2025 and -$1.4 billion for Q1 2025.